---
title: "Beryl Drugs Ltd (524606) — Share Price, Financials & Analysis"
symbol: "524606"
company: "Beryl Drugs Ltd"
canonical: "https://tapetide.com/stocks/524606"
isin: "INE415H01017"
nse_symbol: "BERYLDRUGSLTD"
bse_code: "524606"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 11.2
generated_at: "2026-09-13T20:15:43.009Z"
---

# Beryl Drugs Ltd (524606)

Canonical page: https://tapetide.com/stocks/524606

## Company

- **NSE Symbol:** BERYLDRUGSLTD
- **BSE Code:** 524606
- **ISIN:** INE415H01017
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2006-07-25
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** beryldrugs.com

## About

Incorporated in 1993, Beryl Drugs Ltd
is in the business of pharmaceuticals manufacturing[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:50:07.735476Z.

- **Market Cap:** ₹11.2 Cr
- **Classification:** Microcap
- **P/E (reported):** 19.6
- **EPS (TTM):** ₹1.21
- **EPS (reported):** ₹1.2
- **Book Value:** ₹19.44
- **Price to Book:** 1.24
- **Dividend Yield:** 0%
- **ROE:** 6.09%
- **ROCE:** 11.97%
- **Debt to Equity:** 0.25
- **Revenue (yearly):** ₹18.82 Cr
- **Net Income:** ₹0.48 Cr
- **EBITDA:** ₹1.94 Cr
- **52-Week High:** ₹27.6
- **52-Week Low:** ₹15.92
- **RSI (14):** 55.32

## Tapetide Score

- **Score:** 55 / 100
- **Score date:** 2026-09-04
- **Archetype:** Average Quality, Undemanding Price
- **What it means:** The financials sit mid-range rather than strong, and the multiple is not demanding. Nothing here stands out in either direction, so the read comes down to which single pillar you weight most and whether the next results move it off the middle.
- **Pillar profile:** Quality: Average · Valuation: Fair · Momentum: Rising
- **Percentile:** 70.1 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 41.99 | 9% |
| growth | 44.08 | 9% |
| momentum | 76.98 | 12% |
| ownership | 51.93 | 24% |
| quality | 59.17 | 22% |
| valuation | 59.35 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Debtor days have improved from 79.1 to 39.5 days.
- Company's working capital requirements have reduced from 55.1 days to 39.3 days

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 6.60% over past five years.
- Promoter holding is low: 27.8%
- Company has a low return on equity of 6.42% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 221.95% | 6.45% | 676.47% |
| ebitda margin growth | -53.85% | -11.96% | 4.56% | 165.72% |
| net income growth | -66.67% | -20% | -18% | 44% |
| revenue growth | 38.18% | -16.73% | -10% | 7% |
| roce | — | -4.7% | -4.32% | 7.86% |
| roe | — | -29.27% | 8.07% | 101.66% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 8.09 | 7.66 | 3.21 | 6.29 | 5.64 | 5.4 | 5.22 | 4.83 | 5.16 | 3.85 | 5.47 | 7.57 |
| Expenses | 7.37 | 6.87 | 3.19 | 5.3 | 5.08 | 4.81 | 4.72 | 4.28 | 4.43 | 4.05 | 4.13 | 6.92 |
| Operating Profit | 0.72 | 0.79 | 0.02 | 0.99 | 0.56 | 0.59 | 0.5 | 0.55 | 0.73 | -0.2 | 1.34 | 0.65 |
| OPM % | 8.9 | 10.31 | 0.62 | 15.74 | 9.93 | 10.93 | 9.58 | 11.39 | 14.15 | -5.19 | 24.5 | 8.59 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0.1 | 0.11 | 0.13 | 0.21 | 0.12 | 0.12 | 0.08 | 0.1 | 0.08 | 0.09 | 0.07 | 0.06 |
| Depreciation | 0.29 | 0.31 | 0.32 | 0.28 | 0.33 | 0.31 | 0.32 | 0.38 | 0.39 | 0.32 | 0.4 | 0.32 |
| Profit before tax | 0.33 | 0.37 | -0.43 | 0.5 | 0.11 | 0.16 | 0.1 | 0.07 | 0.26 | -0.61 | 0.87 | 0.27 |
| Tax % | 18.18 | 16.22 | -16.28 | 26 | 90.91 | 62.5 | -50 | 71.43 | 96.15 | -72.13 | 34.48 | 18.52 |
| Net Profit | 0.27 | 0.31 | -0.35 | 0.37 | 0.01 | 0.05 | 0.15 | 0.02 | 0.01 | -0.17 | 0.56 | 0.22 |
| EPS in Rs | 0.53 | 0.61 | -0.69 | 0.73 | 0.02 | 0.1 | 0.3 | 0.04 | 0.02 | -0.34 | 1.1 | 0.43 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 15.08 | 12.81 | 12.78 | 14.03 | 14.48 | 26.84 | 26.73 | 21.15 | 19.31 | 22.05 |
| Expenses | 14.04 | 11.78 | 11.87 | 12.58 | 14.04 | 24.84 | 24.45 | 19.91 | 16.89 | 19.53 |
| Operating Profit | 1.04 | 1.03 | 0.91 | 1.45 | 0.44 | 2 | 2.28 | 1.24 | 2.42 | 2.52 |
| OPM % | 6.9 | 8.04 | 7.12 | 10.33 | 3.04 | 7.45 | 8.53 | 5.86 | 12.53 | 11.43 |
| Other Income | 0.69 | 0.24 | 0.23 | 0.64 | 0.16 | 0.27 | 0.4 | 1.41 | 0 | 0 |
| Interest | 0.13 | 0.15 | 0.32 | 0.47 | 0.46 | 0.47 | 0.47 | 0.54 | 0.34 | 0.3 |
| Depreciation | 0.33 | 0.32 | 0.66 | 1.27 | 1.09 | 0.81 | 1.2 | 1.25 | 1.49 | 1.43 |
| Profit before tax | 1.27 | 0.8 | 0.16 | 0.35 | -0.95 | 0.99 | 1.01 | 0.86 | 0.59 | 0.79 |
| Tax % | 22.05 | 26.25 | 68.75 | 31.43 | -30.53 | 22.22 | 23.76 | 33.72 | 27.12 | — |
| Net Profit | 0.99 | 0.59 | 0.05 | 0.24 | -0.66 | 0.77 | 0.77 | 0.58 | 0.42 | 0.62 |
| EPS in Rs | 1.95 | 1.16 | 0.1 | 0.47 | -1.3 | 1.52 | 1.52 | 1.14 | 0.83 | 1.21 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 |
| Reserves | 0.79 | 1.57 | 2.43 | 2.53 | 2.84 | 2.2 | 2.97 | 3.83 | 4.41 | 4.79 |
| Borrowings | 1.72 | 1.48 | 3.25 | 5.23 | 5.12 | 5.29 | 4.54 | 5.09 | 4.07 | 2.44 |
| Other Liabilities | 2.85 | 2.69 | 3.8 | 4.07 | 5.6 | 5.25 | 4.92 | 3.48 | 2.39 | 2.64 |
| Total Liabilities | 10.45 | 10.83 | 14.57 | 16.92 | 18.65 | 17.83 | 17.52 | 17.49 | 15.96 | 14.96 |
| Fixed Assets | 2.25 | 2.22 | 1.96 | 8.6 | 7.52 | 6.04 | 6.03 | 6.17 | 6.2 | 7.04 |
| CWIP | 0 | 0.08 | 6.24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.49 | 0.22 | 0.48 | 0.56 | 0.12 | 0.16 | 0.15 | 0 | 0 | 0 |
| Other Assets | 7.71 | 8.31 | 5.89 | 7.76 | 11.01 | 11.63 | 11.34 | 11.32 | 9.76 | 7.92 |
| Total Assets | 10.45 | 10.83 | 14.57 | 16.92 | 18.65 | 17.83 | 17.52 | 17.49 | 15.96 | 14.96 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.37 | -0.1 | 3.35 | 0.18 | 0.34 | -0.29 | 2.48 | 0.82 | 2.64 | 3.65 |
| Cash from Investing Activity | 0.32 | -0.03 | -5.01 | -1.55 | 0.26 | 0.54 | -1.3 | -1.08 | -0.4 | -2.16 |
| Cash from Financing Activity | -0.19 | -0.36 | 1.62 | 1.67 | -0.54 | -0.43 | -1.17 | 0.1 | -1.55 | -2.03 |
| Net Cash Flow | 0.5 | -0.49 | -0.04 | 0.3 | 0.06 | -0.18 | 0.01 | -0.16 | 0.69 | -0.54 |
| Free Cash Flow | 0.19 | -0.01 | -2.87 | -1.7 | 0.1 | 0.1 | 1.73 | -0.51 | 1.35 | -0.17 |
| CFO/OP | -833 | 1 | 350 | 36 | 25 | -43 | 127 | 45 | 227 | 157 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 102.47 | 116.91 | 98.02 | 98.53 | 118.11 | 112.17 | 93.83 | 103.51 | 94.23 | 39.51 |
| Inventory Days | 151.29 | 53.1 | 39.74 | 486.67 | 1135 | — | 245.67 | — | — | 116.93 |
| Days Payable | 65.24 | 57.03 | 93.6 | 755.17 | 1110 | — | 758.08 | — | — | 53.42 |
| Cash Conversion Cycle | 188.52 | 112.97 | 44.16 | -169.97 | 143.11 | 112.17 | -418.57 | 103.51 | 94.23 | 103.02 |
| Working Capital Days | 67.31 | 71.89 | -6.55 | 13.99 | 38.76 | 47.14 | 46.51 | 57.9 | 68 | 39.32 |
| ROCE % | -2.26 | 11.94 | 9.94 | 4.06 | 2.86 | -3.82 | 11.6 | 11.05 | 10.15 | 7.18 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 26.38% | 26.38% | 26.38% | 26.38% | 26.38% | 26.38% | 26.38% | 26.38% | 26.38% | 26.38% | 27.48% | 27.82% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 67.87% | 67.51% | 66.26% | 68.06% | 67.92% | 68.35% | 68.53% | 68.69% | 68.71% | 66.25% | 64.94% | 63.56% |
| Others | 5.75% | 6.11% | 7.35% | 5.55% | 5.7% | 5.26% | 5.08% | 4.93% | 4.91% | 7.37% | 7.59% | 8.62% |
| No. of Shareholders | 6805 | 6852 | 7257 | 7325 | 7364 | 7429 | 7431 | 7415 | 7446 | 7409 | 7349 | 7309 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 6 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 24.28 | Sell |
| EMA (10) | 24.11 | Sell |
| SMA (20) | 23.48 | Buy |
| EMA (20) | 23.7 | Buy |
| SMA (50) | 22.76 | Buy |
| EMA (50) | 23.04 | Buy |
| SMA (100) | 22.33 | Buy |
| EMA (100) | 22.61 | Buy |
| SMA (200) | 22.16 | Buy |
| EMA (200) | 22.48 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 54.2 | Neutral |
| MACD (12,26,9) | 0.5 | Buy |
| Stochastic (14,3,3) | 46.33 | Neutral |
| ADX (14) | 41.25 | Buy |
| Williams %R (14) | -59.8 | Neutral |
| ATR (14) | 2.04 | High Volatility |
| ROC (12) | 8.31 | Buy |
| Stoch RSI (14) | 45.42 | Neutral |
| UO (7,14,28) | 61.22 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-06 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=033223e1-7387-48c8-9261-e02932fc5b24.pdf) |
| 2026-09-03 | [33RD ANNUAL GENERAL MEETING NOTICE TO BE HELD ON 29TH SEPTEMBER 2026 AT 11 A.M. AT KANCHAN PALACE COMMUNITY HAII NIPANIA RING ROAD INDORE](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e744c22-c01f-4d98-8d00-4885d4a90c2e.pdf) |
| 2026-09-03 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c4fa5f0-115b-4d4e-9184-0b69200094da.pdf) |
| 2026-09-03 | [RECORD DATE FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ff23e76-ba41-4440-b63c-6bf22e991ac8.pdf) |
| 2026-09-03 | [EVOTING DATE FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=316010ab-6bb7-4670-bd94-76f2cb6facb2.pdf) |
| 2026-09-02 | [Board Meeting Outcome for OUTCOME OF BOARD MEETING](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66dabcf2-78d4-4dab-bde0-84b2bec9d821.pdf) |
| 2026-09-02 | [ANNUAL BOOK CLOSURE](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2666dd09-ffaf-4e2d-9750-67185e1c72f7.pdf) |
| 2026-08-27 | [Board Meeting Intimation for Approve Board Report And Other Matters Related To 33Rd Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ce92c6e-776f-49cc-881a-55d66bdbacdc.pdf) |
| 2026-08-20 | [Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95A3590B_B977_45A4_BC38_88301A6B284B_092644.pdf) |
| 2026-08-19 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=AA012F52_5E8E_4CC9_95D6_AED504C340AD_111737.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-11 | [UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b7a0c8d-5bda-44e3-9250-472f462a669c.pdf) |
| 2026-05-28 | [AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8255078-fda3-41cf-bb4b-f383ad115fa1.pdf) |
| 2026-02-09 | [UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2bdf35fc-34a9-4d97-b0de-b4909986fd95.pdf) |
| 2025-11-13 | [UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH SEPTEMBER 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48a1706c-ed8b-4026-9206-0a6bb2ccccbd.pdf) |
| 2025-08-07 | [UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45c4c1f3-0d10-4765-bd9d-8921e1b13053.pdf) |
| 2025-05-30 | [AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcc79643-4f1d-4584-b4f4-52f61bb18dda.pdf) |
| 2025-02-08 | [UNAUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c909969-899d-4299-a8b8-768d7a1f8565.pdf) |
| 2024-11-13 | [UNAUDITED FINANCIAL RESULTS FOR THE QUARTER/HALF YEAR ENDED 30TH SEPTEMBER, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32d20fe7-cd3f-42b6-966d-6dc7abbf2849.pdf) |
| 2024-08-09 | [Unaudited Financial Results For The Quarter Ended 30Th June, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93dcdf78-26ae-498a-815b-df9673dfafa1.pdf) |
| 2024-05-30 | [AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b49507f-6d5d-478e-a4bf-81315bef9b64.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - EOGM 16 Mar 2026 to regularise Shailendra Pathak as WTD; appoint Neha Sarda; approve RPT with Aminova; Q3 results. | [Board Meeting Outcome for OUTCOME OF BOARD MEETING 9 Feb - EOGM 16 Mar 2026 to regularise Shailendra Pathak as WTD; appoint Neha Sarda; approve RPT with Aminova; Q3 results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/05fa95c9-ddfe-4bba-93cd-e96097f5d135.pdf) |
| 8 Apr - Filed Regulation 40(9) compliance certificate for year ended 31 March 2026; no share transfers occurred. | [COMPLIANCE CERTIFICATE 8 Apr - Filed Regulation 40(9) compliance certificate for year ended 31 March 2026; no share transfers occurred.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e420ebce-8678-4b0d-92fd-20f7ebd8fb74.pdf) |
| 8 Apr - Beryl Drugs confirms it is not a Large Entity/Large Corporate as of 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 8 Apr - Beryl Drugs confirms it is not a Large Entity/Large Corporate as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b114fafd-3bb8-4ab9-8812-76704869aacd.pdf) |
| 7 Feb - Dear Sir/Madam, pursuant to Regulation 33 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015 please find enclosed a … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 7 Feb - Dear Sir/Madam, pursuant to Regulation 33 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015 please find enclosed a …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f6b491c7-8c40-472b-b65d-d3159c300105.pdf) |
| 6h - Promoter Sudhir Sethi acquired 7,500 shares (0.14%); disclosure filed 25-Mar-2026 under SEBI PIT Reg 7(2). | [DISCLOSURE UNDER REGULATION 7(2) OF SEBI (PROHIBITION OF INSIDER TRADING) REGULATIONS, 2015 6h - Promoter Sudhir Sethi acquired 7,500 shares (0.14%); disclosure filed 25-Mar-2026 under SEBI PIT Reg 7(2).](https://www.bseindia.com/xml-data/corpfiling/AttachLive/070379ca-2ebf-423a-bcb8-25c7c4cbc9f7.pdf) |
| 6h - Promoter Sudhir Sethi acquired 7,500 shares (0.14%) on 24-03-2026; holding rose to 4,93,983 (9.72%). | [DISCLOSURE UNDER REGULATION 29(2) OF SEBI(SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011 6h - Promoter Sudhir Sethi acquired 7,500 shares (0.14%) on 24-03-2026; holding rose to 4,93,983 (9.72%).](https://www.bseindia.com/xml-data/corpfiling/AttachLive/48b5007a-b3a1-4332-b7f6-57ae6c4c4ce6.pdf) |
| 6 Jan - COMPLIANCE CERTIFICATE UNDER REGULATION 74(5) FOR THE QUARTER ENDED 31ST DECEMBER, 2025 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Jan - COMPLIANCE CERTIFICATE UNDER REGULATION 74(5) FOR THE QUARTER ENDED 31ST DECEMBER, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3ae45b89-d00b-4875-b6f8-c1770df213a1.pdf) |
| 6 Apr - Filed quarterly compliance certificates for 31 March 2026, including Regulation 74(5), 7(3) and 57(5) non-applicability. | [Compliance-57 (5) : intimation after the end of quarter 6 Apr - Filed quarterly compliance certificates for 31 March 2026, including Regulation 74(5), 7(3) and 57(5) non-applicability.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2ead45ff-cc40-4ed7-8031-ef35b692cc1b.pdf) |
| 5h - Sudhir Sethi acquired 11,786 shares (0.23%) of Beryl Drugs; disclosed 11.03.2026. | [Submission Of Disclosure Under Regulations 7 (2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 5h - Sudhir Sethi acquired 11,786 shares (0.23%) of Beryl Drugs; disclosed 11.03.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/79150e3b-146e-4b3e-a5f4-666b6f962057.pdf) |
| 5h - Promoter Sudhir Sethi bought 11,786 shares (0.23%), raising holding to 8.88% on 10-03-2026. | [Submission Of Disclosure Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 5h - Promoter Sudhir Sethi bought 11,786 shares (0.23%), raising holding to 8.88% on 10-03-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9637ca76-8cef-4257-9d74-ba6aaca81cc3.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0859bde0-c500-44be-8939-87706b7abe6a.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/173a40b8-8f90-41c5-b9ef-d6d498ceb0d3.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/09b21db6-db40-4691-a8a7-4bed8c02a948.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fd2950de-4087-4db0-88c2-33b06e5525ae.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c463c901-b204-4af6-a13a-00ad0bc0b982.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3017aed4-1f9a-4872-84e5-9da6fb2badf3.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/539979/75302539979.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524606/75785524606.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/539979/69977539979.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524606/70751524606.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T20:15:43.009Z.